Morning Market Gainers
February 13, 2015 at 09:45 AM EST
Cytokinetics, Incorporated (NASDAQ: CYTK) shares climbed 18.46% to $7.69 on Q4 results. Cytokinetics reported Q4 earnings of $8.4 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.